Rapid detection of Mycoplasma hyopneumoniae by recombinase-aided amplification combined with the CRISPR/Cas12a system
2024

Rapid Detection of Mycoplasma hyopneumoniae Using RAA and CRISPR/Cas12a

Sample size: 76 publication 10 minutes Evidence: high

Author Information

Author(s): Li Kaili, Luo Tingyu, Zhang Yu, Li Changwen, Chen Hongyan, Xia Changyou, Gao Caixia

Primary Institution: Harbin Veterinary Research Institute, Chinese Academy of Agricultural Sciences

Hypothesis

Can a recombinase-aided amplification (RAA) assay combined with the CRISPR/Cas12a system effectively detect Mycoplasma hyopneumoniae?

Conclusion

The RAA-CRISPR/Cas12a system provides a rapid, highly sensitive, and specific method for detecting Mycoplasma hyopneumoniae.

Supporting Evidence

  • The RAA-CRISPR/Cas12a system achieved a detection limit of 1 copy/µL.
  • The system showed no cross-reactivity with other respiratory pathogens.
  • Clinical testing demonstrated a 100% positive rate in lung tissue samples.

Takeaway

Scientists created a quick test to find a germ that makes pigs sick, using a special method that works really well and is easy to use.

Methodology

The study used a recombinase-aided amplification (RAA) assay combined with the CRISPR/Cas12a system to detect Mycoplasma hyopneumoniae in clinical samples.

Limitations

The study did not address the potential for false negatives in low-prevalence settings.

Participant Demographics

The study involved clinical samples from pigs, including 51 lung tissue samples and 25 nasal swab samples.

Statistical Information

P-Value

p<0.001

Statistical Significance

p<0.05

Digital Object Identifier (DOI)

10.3389/fcimb.2024.1469558

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication